Alle verbonden artikelen

Characterization and Clinical Utility of <i>BRAF</i>^V600 Mutation Detection Using Cell-Free DNA in Patients with Advanced Melanoma.

Auteurs : Rutkowski P, Pauwels P, Kerger J, Jacobs B, Maertens G, Gadeyne V, Thielemans A, de Backer K, Neyns B
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features.

Auteurs : Raffenne J, Martin FA, Nicolle R, Konta M, Blum Y, Torrisani J, Puleo F, Bachet JB, Svrcek M, Bardier-Dupas A, Emile JF, Demetter P, Radman M, Van Laethem JL, Hammel P, Rebours V, Paradis V, Couvelard A, Cros J
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer.

Auteurs : Condorelli M, Bruzzone M, Ceppi M, Ferrari A, Grinshpun A, Hamy AS, de Azambuja E, Carrasco E, Peccatori FA, Di Meglio A, Paluch-Shimon S, Poorvu PD, Venturelli M, Rousset-Jablonski C, Senechal C, Livraghi L, Ponzone R, De Marchis L, Pogoda K, Sonnenblick A, Villarreal-Garza C, Córdoba O, Teixeira L, Clatot F, Punie K, Graffeo R, Dieci MV, Pérez-Fidalgo JA, Duhoux FP, Puglisi F, Ferreira AR, Blondeaux E, Peretz-Yablonski T, Caron O, Saule C, Ameye L, Balmaña J, Partridge AH, Azim HA, Demeestere I, Lambertini M
Jaar : 2021
Journal : ESMO Open
Volume : 6
Pagina's : 100300

Adjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.

Auteurs : Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, Gelber Rd, de Azambuja E, Fielding A, Balmaña J, Domchek SM, Gelmon KA, Hollingsworth SJ, Korde LA, Linderholm B, Bandos H, Senkus E, Suga JM, Shao Z, Pippas AW, Nowecki Z, Huzarski T, Ganz PA, Lucas PC, Baker N, Loibl S, McConnell R, Piccart-Gebhart M, Schmutzler R, Steger GG, Costantino JP, Arahmani A, Wolmark N, Mcfadden E, Karantza V, Lakhani SR, Yothers G, Campbell C, Geyer CE Jr
Jaar : 2021
Journal : N Engl J Med
Volume : 384
Pagina's : 2394-2405

Tolerability and toxicity of trastuzumab or trastuzumab?+?lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).

Auteurs : Pondé N, Agbor-Tarh D, Dal Lago L, Korde LA, Hilbers F, Jackisch C, Werner O, Gelber Rd, Jatoi A, Dueck AC, Moreno-Aspitia A, Sotiriou C, de Azambuja E, Piccart-Gebhart M
Jaar : 2021
Journal : Breast Cancer Res Treat
Volume : 185
Pagina's : 107-116

The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases.

Auteurs : Bohlok A, Lucidi V, Bouazza F, Daher A, Germanova D, Van Laethem JL, Hendlisz A, Donckier V
Jaar : 2020
Journal : World J Surg Oncol
Volume : 18
Pagina's : 106

Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial.

Auteurs : Lambertini M, Agbor-Tarh D, Metzger-Filho O, Ponde NF, Poggio F, Hilbers FS, Korde LA, Chumsri S, Werner O, Del Mastro L, Caparica R, Moebus V, Moreno-Aspitia A, Piccart-Gebhart M, de Azambuja E
Jaar : 2020
Journal : ESMO Open
Volume : 5

Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity.

Auteurs : Engelman D, Moreau M, Lepida A, Zaouak Y, Paesmans M, Awada A
Jaar : 2020
Journal : ESMO Open
Volume : 5

Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer.

Auteurs : Mierzynska J, Taye M, Pe M, Coens C, Martinelli F, Pogoda K, Velikova G, Bjelic-Radisic V, Cardoso F, Brain E, Ignatiadis M, Piccart-Gebhart M, Van Tienhoven G, Mansel R, Wildiers H, Bottomley A
Jaar : 2020
Journal : Eur J Cancer
Volume : 125
Pagina's : 69-82

Atezolizumab in metastatic triple-negative breast cancer: IMpassion130 and 131 trials - how to explain different results?

Auteurs : Franzoi MA, de Azambuja E
Jaar : 2020
Journal : ESMO Open
Volume : 5

Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel.

Auteurs : Bregni G, Sticca T, Camera S, Akin Telli T, Craciun L, Trevisi E, Pretta A, Kehagias P, Leduc S, Senti C, Deleporte A, Vandeputte C, Saad ED, Kerger J, Gil T, Piccart-Gebhart M, Awada A, Demetter P, Larsimont D, Hendlisz A, Aftimos P, Sclafani F
Jaar : 2020
Journal : Acta oncol (Stockholm)
Volume : 59
Pagina's : 1438-1446

Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis.

Auteurs : de Azambuja E, Brandão M, Wildiers H, Laenen A, Aspeslagh S, Fontaine C, Collignon J, Lybaert W, Verheezen J, Rutten A, Vuylsteke P, Goeminne JC, Demey W, Van Beckhoven D, Deblonde J, Rottey S, Geukens T, Punie K
Jaar : 2020
Journal : ESMO Open
Volume : 5

Adjuvant chemotherapy for gastrointestinal cancers: we can do much better.

Auteurs : Sclafani F, Hendlisz A
Jaar : 2020
Journal : Curr Opin Oncol

A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer.

Auteurs : Liberale G, Pop FC, Polastro L, Kerger J, Moreau M, Chintinne M, Larsimont D, Nogaret JM, Veys I
Jaar : 2020
Journal : J Visc Surg
Volume : 157
Pagina's : 79-86

Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemics.

Auteurs : Fares JE, El Tomb P, Khalil LE, Atwani RW, Moukadem HA, Awada A, El Saghir NS
Jaar : 2020
Journal : Cancer Treat Rev
Volume : 89
Pagina's : 102066

The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC).

Auteurs : Eiger D, Wagner M, Pondé NF, Nogueira MS, Buisseret L, de Azambuja E
Jaar : 2020
Journal : Acta oncol (Stockholm)
Volume : 59
Pagina's : 723-725

Neoadjuvant immunotherapy in breast cancer: a paradigm shift?

Auteurs : Fountzila E, Ignatiadis M
Jaar : 2020
Journal : Ecancermedicalscience
Volume : 14
Pagina's : 1147

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using ¹⁸F-FES PET/CT imaging.

Auteurs : Jager A, de Vries EGE, der Houven van Oordt CWM, Neven P, Venema CM, Glaudemans AWJM, Wang Y, Bagley RG, Conlan MG, Aftimos P
Jaar : 2020
Journal : Breast Cancer Res
Volume : 22
Pagina's : 97

ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy.

Auteurs : Perez-Gracia JL, Awada A, Calvo E, Amaral T, Arkenau HT, Gruenwald V, Bodoky G, Lolkema MP, Di Nicola M, Penel N, Vera R, Sanmamed MF, Douillard JY
Jaar : 2020
Journal : ESMO Open
Volume : 5

Analysis of inflammatory markers and hormones in old cancer patients: A descriptive study.

Auteurs : De Breucker S, Luce S, Njemini R, Bautmans I, Decoster L, Mets T, Pepersack T
Jaar : 2020
Journal : Exp Gerontol
Volume : 130
Pagina's : 110787